BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37536379)

  • 21. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
    Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
    Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of de novo HLA donor specific antibodies (HLA-DSA), HLA antibodies (HLA-Ab) and allograft rejection post blood transfusion in kidney transplant recipients.
    Jalalonmuhali M; Carroll RP; Tsiopelas E; Clayton P; Coates PT
    Hum Immunol; 2020 Jul; 81(7):323-329. PubMed ID: 32327243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
    Halleck F; Khadzhynov D; Liefeldt L; Schrezenmeier E; Lehner L; Duerr M; Schmidt D; Bamoulid J; Lachmann N; Waiser J; Budde K; Staeck O
    Nephrol Dial Transplant; 2016 Dec; 31(12):2143-2149. PubMed ID: 27369852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
    San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
    Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-Mediated Rejection Due to Preexisting versus
    Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
    J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
    Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
    Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Taylor CJ; Nickerson P
    Transplantation; 2018 Aug; 102(8):1338-1343. PubMed ID: 29443827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
    Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
    Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
    Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
    J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eplet matching in pediatric heart transplantation: The SickKids experience.
    Cardoso B; Wang J; Kiernan J; Dipchand AI
    J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of T and B Cell Epitopes to Predict the Risk of
    Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
    Front Immunol; 2020; 11():2000. PubMed ID: 32973806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-mediated rejection owing to donor-specific HLA-DQA1 antibodies after renal transplantation: A case report.
    Liu W; Kang ZY; Wang ZL; Li DH
    Transpl Immunol; 2022 Aug; 73():101607. PubMed ID: 35477043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
    Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
    Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
    Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
    Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):275-283. PubMed ID: 33495290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
    Gavroy B; Timmermans T; Van Caenegem O; Mastrobuoni S; Jacquet L; Latinne D; Poncelet AJ
    Transpl Immunol; 2022 Dec; 75():101706. PubMed ID: 36113729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney Transplantation With Ultralong-Term (42 Years) Survival of a 100-Year-Old Graft.
    Nascimento E; Lucas-Junior FM; Fabreti-Oliveira RA; Vilela B; Tavora ER; Silva JP; Salomão-Filho A
    Transplant Proc; 2016 Nov; 48(9):3079-3084. PubMed ID: 27932151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
    Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
    Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.